Loading clinical trials...

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension | Clinical Trials | Clareo Health

COMPLETEDNCT03078244

Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension

Project aims to determine the number of individuals with treatment resistant hypertension and to define the characteristics of these patients and estimate disease frequency. The study will be a retros...

Lead sponsor: Emerald Clinical Inc.•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Endocalyx in Treatment Resistent Hypertension

NCT06940011 · Treatment Resistant Hypertension

UNKNOWNNA

Investigation of a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease

NCT03317951 · Heart Failure, Atrial Fibrillation, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 19, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,500

Start dateNov 2016

Last updatedFeb 19, 2018

Condition

Treatment Resistant Hypertension

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions